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PATIENT SAFETY AND QUALITY IMPROVEMENT EXEMPLARS
Evaluation of nurse-or pharmacist-driven protocol for long-
acting insulin titration in adult patients with type 2 diabetes
Ruth Manzi, PharmD,1 Corinn Martineau, PharmD, BCACP, CDOE,1 Carmine LaPorta, RN,2               
Mary Muca, RN,2 Samantha Marrier, MPH, LPN,3 Donald Medd, MD,4 Jennifer Aronson, MD4 
1Department of Pharmacy, Maine Medical Center, Portland, ME, 2Department of Nursing, Maine Medical Center, Portland, 
ME, 3MMC Quality & Safety, Maine Medical Center, Portland, ME, 4Department of Medicine, Maine Medical Center, 
Portland, ME
Introduction:  Studies have supported using a protocol to optimize insulin therapy with insulin titration. We implemented 
a protocol for long-acting insulin titration (LAIT), managed by registered nurse care managers (RNCMs) 
and clinical pharmacists (CPs), in a primary care setting. We aimed to determine if implementing a LAIT 
protocol managed by RNCMs and CPs would effectively improve the control of type 2 diabetes (T2D).
Methods:  This retrospective analysis included patients who were receiving care at a primary care clinic within 
our health care system. Participants were 18 years of age and older with T2D and a hemoglobin A1C 
(A1C) > 8%. Demographic and A1C data were collected before and after enrollment in the protocol. The 
primary outcome was a change in A1C level between measurements taken before and after completing 
the protocol. The secondary outcome was achievement of the A1C goal.
Results:  Participants experienced a significant decrease in A1C (9.97 ± 1.85% pre-protocol to 8.60 ± 1.67% 
post-protocol, P < .001). The median absolute change in A1C was -1.0 [interquartile range, -2.48 to 
-0.10]. Overall, 77 (37.7%) patients acheived an A1C < 8% and 31 (15.2%) achieved an A1C of < 7%. 
Barriers to adhering to the full protocol included needle phobia and lack of patient engagement.
Discussion:  The LAIT protocol successfully improved glycemic control among patients with T2D. Future 
enhancements could focus on analyzing referral use and patient engagement.
Conclusions:  The LAIT protocol allows RNCMs and CPs to significantly contribute to achieving glycemic goals in 
patients with uncontrolled diabetes.
Keywords:  insulin titration, primary care, insulin therapy, type 2 diabetes
In the United States, over 30 million people (9.4% of the population) are living with diabetes.1 While managing diabetes and associated 
hyperglycemia can help to prevent microvascular 
and macrovascular complications, many patients 
with diabetes do not optimally control their 
diabetes due to the complexity of their disease 
and clinical inertia.2,3 The Standards of Medical 
Care in Diabetes recommend using a collaborative 
approach to managing diabetes in the primary care 
setting, which includes pharmacologic therapy.3 
When patients are not achieving their hemoglobin 
A1C (A1C) target, despite oral antihyperglycemic 
therapy, basal insulin is a potential next step. In the 
outpatient setting, demands for a provider’s time 
and attention may lead to inconsistent methods for 
initiating and managing insulin therapy.
The American Diabetes Association recommends 
that a long-acting insulin regimen be adjusted 
once or twice weekly until fasting blood glucose 
(FBG) targets are achieved.3,5 Although studies 
have supported using a protocol to optimize insulin 
therapy with insulin titration,4,6 there are limited 
studies that address efficient titration of basal 
insulin by healthcare providers other than the 
primary care provider (PCP). The purpose of this 
quality improvement (QI) project was to evaluate 
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the implementation and performance of a protocol 
for long-acting insulin titration (LAIT) in the primary 
care setting. The insulin titration was managed by 
registered nurse care managers (RNCM) or clinical 
pharmacists (CPs).
METHODS
Our retrospective analysis of this QI project 
included patients participating in the LAIT protocol 
between July 1, 2016 and January 23, 2019. 
The patients were managed at 10 primary care 
practices in Southern Maine. These practices were 
staffed by 10 RNCMs and 3 CPs during the project. 
Patients eligible for enrollment were 18 years of 
age or older with type 2 diabetes (T2D) and an 
A1C of > 8%. Patients enrolled agreed to self-
monitor their blood glucose daily, maintain contact 
with RNCMs or CPs every 3-7 days for titration, 
and adhere to insulin therapy (self-reported by the 
patient). At the start of the protocol, patients new 
to insulin therapy were started on 10 units of long-
acting insulin nightly, while patients already being 
treated with long-acting insulin were maintained on 
their current dose. Insulin doses were increased 
by 2 units every 3–7 days until a FBG goal of 80-
150 mg/dL was reached. Patients were allowed 
to continue their current oral antihyperglycemic 
agent(s) and non-insulin injectables as prescribed 
by their PCP. Providers were contacted in the case 
of hypoglycemic episodes (Figure 1).
Demographic data, such as age, practice location, 
and referral date, were obtained and used to collect 
accurate pre- and post-protocol A1C values from 
the electronic medical record. These data were 
summarized with descriptive statistics. The primary 
outcome measure for protocol performance was 
the change in A1C level between measurments 
taken before and after completing the protocol. The 
secondary outcome was the percentage of patients 
who achieved their A1C goal, defined as an A1C 
< 8% and < 7%. Pre- and post-protocol A1Cs 
were calculated as mean ± standard deviation or 
median (interquartile range, IQR), as appropriate, 
for continuous data and as frequency (n, %) for 
categorical data. Post-protocol A1C was analyzed 
if the collection occurred at least 3 months after the 
initial A1C. If patients had multiple A1C measurments 
during the protocol, the A1C furthest from the start 
of protocol was analyzed. Paired differences in 
pre- and post-protocol A1C was evaluated by the 
Wilcoxon signed rank test. All statistical analyses 
were performed using SPSS Statistical software, 
version 25 (IBM SPSS Inc, Armonk, NY). This study 
followed Squire guidelines and was deemed a QI 
project by the Maine Medical Center Institutional 
Review Board.
RESULTS
Among 463 patients with T2D who enrolled in 
the protocol, 205 patients aged 26-88 years 
(mean 60.0 ± 11.8 years) from 10 practices were 
eligible for inclusion in the analysis. Patients not 
meeting inclusion criteria were excluded. Figure 
2 documents the process for identifying the final 
study group. Patients enrolled in the LAIT protocol 
showed a significant decrease in A1C (9.97 ± 
1.85% pre-protocol to 8.60 ± 1.67% post-protocol; 
P < .001). The median absolute decrease in A1C 
was 1.0% [IQR, -2.48 to -0.10%]. Overall, an A1C 
of < 8% was achieved in 77 (37.7%) patients. Of 
these, 31 (15.2%) patients achieved further control 
with an A1C < 7%.
DISCUSSION
Interprofessional teams provide patient-centered 
care for diabetes. The LAIT protocol allows RNCMs 
and CPs to substantially contribute to achieving 
glycemic goals in patients with uncontrolled 
T2D. This QI project resulted in a significant 1% 
reduction in A1C among patients enrolled the 
LAIT protocol. Antihyperglycemic agents currently 
recommended by practice guidelines provide 
a comparable reduction. For example, sodium-
glucose cotransporter 2 inhibitors (SGLT-2i) reduce 
A1C by an average of 0.5-1.0%, and dipeptidyl 
peptidase 4 inhibitors (DPP-4i) reduce A1C by as 
little as < 0.7%.7 Thus, the LAIT protocol, carried out 
by a RNCM or CP, may more effectively reduce A1C 
than starting an additional oral antihyperglycemic 
agent. Previous work compared pharmacist- versus 
physician-managed insulin titration. For example, in 
a retrospective, matched, case-control study, Pitlick 
and colleagues compared pharmacist-managed 
insulin titration versus standard care in a primary 
care clinic serving ethnically diverse, underserved 
patients. Standard of care was described as 
patients who were managed by the PCP group 
and excluded if they had any interaction with a CP 
or endocrinologist. At 6 months, the investigators 
found a significant difference in the mean A1C 
between groups, favoring pharmacist management 
(1.0%, 95% CI, 0.2 to 1.6, P = .009).6 Our study and 
previous work support the use of insulin titration by 
other members of the health care team, such as a 
2
Journal of Maine Medical Center, Vol. 2 [2020], Iss. 2, Art. 5
https://knowledgeconnection.mainehealth.org/jmmc/vol2/iss2/5
DOI: 10.46804/2641-2225.1040
Figure 1. Algorithm for long-acting insulin titration.
SQ: subcutaneously, FBG: fasting blood glucose, CP: clinical pharmacist, RNCM: registered nurse care manager






Cases excluded from analysis, n = 258
Did not engage with protocol, n = 84
No post-A1C value collected, n = 48
CP or RNCM did not reach out after protocol placed OR 
inadequate outreach (n = 1), n = 21
Does not qualify for protocol, n = 18
Refused enrollment, n = 18
Insulin never titrated, n = 14
Duplicate referral, placed close to original, n = 12
Patient did not start insulin, n = 12
Managed by endocrinology, n = 11
Deceased, n = 11
Location missing, n = 9
Figure 2. Selection process for study group
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RNCM or CP. One advantage to using RNCMs and 
CPs for insulin titration is that patients can access 
them more easily than physicians. Most RNCMs 
and CPs have dedicated time for phone calls to 
follow up with patients more often, and they can 
better serve patients with higher needs, especially 
those with a high burden of disease. Their time is 
also less costly than a physician, further justifying 
the expansion of their role.
One limitation of this project is the inability to 
understand the use of other antihyperglycemic 
agents within the study population and the reported 
incidence of hypoglycemia. Additional limitations 
include failure to easily retrieve information 
regarding the number or frequency of calls made by 
the RNCM or CP, and the number of adjustments 
to the insulin dose. Barriers to effectively using 
the protocol involved lack of patient engagement, 
including needle phobia and failure to return phone 
calls or regularly monitor FBG. Future work should 
include increasing the size of the intervention 
population; investigating adverse outcomes, such 
as the frequency of hypoglycemia and emergency 
department use; and comparing patients on the LAIT 
protocol with standard care or new technologies, 
such as patient-driven phone applications.
CONCLUSION
The implementation of a LAIT protocol in the primary 
care setting significantly decreased A1C and may 
further improve the management of T2D. Our 
findings suggest that at our institution, care team 
members beyond the PCP effectively managed a 
LAIT protocol and helped patients with T2D better 
manage their disease and achieve their therapeutic 
goals.
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